Literature DB >> 16700375

Malaria in late pregnancy in Al Hodeidah Governorate, Yemen.

H K Bassiouny1, M T Al-Maktari.   

Abstract

To investigate the consequences of maternal malaria during late pregnancy, we conducted a preliminary study in the 2 hospitals in Al Hodeidah on 276 women who had uncomplicated vaginal deliveries. Only 17 women had malaria (Plasmodium falciparum), 6 with peripheral parasitaemia and 11 with both peripheral parasitaemia and placental malaria. Coincident infection carried a 9.44 times higher risk of preterm delivery and a 12.2 times greater risk of low birth weight (< 2500 g). Anaemia was diagnosed in 46.4%, associated with malaria in 11.7% of cases. All risk factors, rural residence (OR 5.18), maternal age < 20 years (OR 4.93) and primigravidae (OR 8.29), were significantly associated with malaria infection.

Entities:  

Mesh:

Year:  2005        PMID: 16700375

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

Review 1.  Systematic review and meta-analysis: rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women.

Authors:  Johanna H Kattenberg; Eleanor A Ochodo; Kimberly R Boer; Henk Dfh Schallig; Petra F Mens; Mariska Mg Leeflang
Journal:  Malar J       Date:  2011-10-28       Impact factor: 2.979

2.  High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy.

Authors:  Abdulsalam M Al-Mekhlafi; Mohammed A K Mahdy; Hesham M Al-Mekhlafi; Ahmed A Azazy; Mun Yik Fong
Journal:  Parasit Vectors       Date:  2011-05-27       Impact factor: 3.876

3.  Epidemiology and aetiology of maternal parasitic infections in low- and middle-income countries.

Authors:  Tom Roberts; Courtney A Gravett; Prasad Palani Velu; Evropi Theodoratou; Thor A Wagner; Jian Shayne F Zhang; Harry Campbell; Craig E Rubens; Michael G Gravett; Igor Rudan
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.